Obesity and diabetes rates continue to rise despite decline in consumption of sweetenersWASHINGTON – A comprehensive review of research focusing on the debate between High Fructose Corn Syrup (HFCS) and other sweeteners presented today finds there is no evidence of any significant variation in the way the human body metabolizes HFCS as opposed to standard table sugar, or any difference in impact on risk factors for chronic disease. James M. Rippe, MD, founder and director of the Rippe Lifestyle Institute and professor of biomedical sciences at the University of Central Florida, presented a summary of recent research entitled -- "High...
